Keryx Biopharmaceuticals Inc. ( KERX ) saw a big move last session, as the company's shares fell by nearly 7% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading below the volatile price range of $13.11 to $14.68 since Jan 6, 2015.
On Jan 20, 2015, the company declared that it initiated an underwritten public offering of its common shares worth $100 million.
The medical company has seen a mixed track record when it comes to current year estimate revisions over the past few weeks (0 increases, 1 decrease), and the consensus for earnings hasn't been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
KERX currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
A better-ranked stock in the medical sector is Alexion Pharmaceuticals, Inc. ( ALXN ), which currently carries a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report